Human Splicing factor U2AF 35 kDa subunit Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human Splicing factor U2AF 35 kDa subunit antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human Splicing factor U2AF 35 kDa subunit |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 0.05 mL, 0.1 mL |
| Concentration | n/a |
| Applications | ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Plays a critical role in both constitutive and enhancer-dependent splicing by mediating protein-protein interactions and protein-RNA interactions required for accurate 3'-splice site selection. Recruits U2 snRNP to the branch point. Directly mediates interactions between U2AF2 and proteins bound to the enhancers and thus may function as a bridge between U2AF2 and the enhancer complex to recruit it to the adjacent intron. |
| Immunogen | Immunogen: Recombinant human Splicing factor U2AF 35 kDa subunit protein(1-240aa) Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-19961 / sc-19663 |
| Other Names | [U2 auxiliary factor 35 kDa subunit; U2 small nuclear RNA auxiliary factor 1; U2 snRNP auxiliary factor small subunit; U2AF1; U2AF35; U2AFBP; FP793], [U2AF1; U2AF1; RN; FP793; U2AF35; U2AFBP; RNU2AF1; U2AF35; U2AFBP] |
| Gene, Accession # | [U2AF1], Gene ID: 7307, NCBI: NP_001020374.1, UniProt: Q01081 |
| Catalog # | MBS1499084 |
| Price | $120, $160 |
| Order / More Info | Human Splicing factor U2AF 35 kDa subunit Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies